Explore more Articles in

BioTech

Why Is Penny Stock ProKidney Trading Higher On Tuesday? – ProKidney (NASDAQ:PROK)

ProKidney Corp. PROK stock is trading higher on Tuesday, with a session volume of 39.8 million compared to the average volume of 1.12 million...

US Dollar Regains Footing as Trump Shifts From Tariff Chaos to Control

Remember Trump’s Art of the ? It works. Two weeks ago, I noted that markets had reached "Peak Chaos" and that Trump’s tariff strategy would...

Why Is Microcap Rallybio Stock Trading Higher On Tuesday? – Rallybio (NASDAQ:RLYB), Recursion Pharmaceuticals (NASDAQ:RXRX)

Rallybio Corporation RLYB agreed on Tuesday to sell its interest in REV102, an ENPP1 inhibitor in preclinical development for hypophosphatasia (HPP), to joint venture...

Top 3 Markets for Prop Traders: EUR/USD, Gold, and Nasdaq Explained

Thinking about prop trading but not sure where to kick things off? You’ve come to the right place. Prop firms want traders who can...
BioTech

What’s Going On With Viking Therapeutics Stock On Wednesday? – Viking Therapeutics (NASDAQ:VKTX)

Viking Therapeutics, Inc. VKTX on Wednesday initiated the VANQUISH Phase 3 clinical program for VK2735, the company’s dual agonist of the glucagon-like peptide 1...
BioTech

Gilead Bets On Kymera’s CDK2 Molecular Glue Degrader For New Cancer Therapies – Gilead Sciences (NASDAQ:GILD), Sanofi (NASDAQ:SNY)

Gilead Sciences, Inc. GILD and Kymera Therapeutics, Inc. KYMR on Wednesday entered into an exclusive option and license agreement to accelerate the development and...
BioTech

Evotec’s Collaboration Sparks Hope For Acute Kidney Injury Breakthroughs – Evotec (NASDAQ:EVO)

Evotec SE EVO shares are trading higher in the premarket session on Wednesday. This surge follows the company’s announcement that it has joined the...
BioTech

Amarin Lands Massive European Commercialization Deal For Heart Drug Vazkepa, Stock Surges – Amarin Corp (NASDAQ:AMRN)

Amarin Corporation Plc AMRN on Tuesday entered into an exclusive long-term license and supply agreement with Recordati S.p.A., Italy, to commercialize Vazkepa (icosapent ethyl)...
BioTech

Revolution Medicines To Advance Lead Cancer Drug With Funding Worth $2B – Royalty Pharma (NASDAQ:RPRX), Revolution Medicines (NASDAQ:RVMD)

Revolution Medicines, Inc. RVMD on Tuesday partnered with Royalty Pharma Plc RPRX on $2 billion in flexible funding to support Revolution Medicines’ independent global...
BioTech

FDA Skips Advisory Committee For Capricor’s Duchenne Cell Therapy – Capricor Therapeutics (NASDAQ:CAPR)

Capricor Therapeutics Inc CAPR on Tuesday provided regulatory updates related to its Biologics License Application (BLA) for Deramiocel, the company’s lead cell therapy candidate...
1...91011...18Page 10 of 18

- A word from our sponsors -

Most Popular

Disclaimer: The content provided is for informational purposes only. We aim to keep the content current and accurate by updating it frequently. Sometimes the actual data can differ from what's stated on our website. Buttonwoodnews.com is an independent platform. While we are independent, we may be compensated for advertisements, sponsored products, or when you click on a link on our website. The contributors and authors are not registered or certified financial advisors. You should consult a financial professional before making any financial decisions.

Copyright © Button Wood News.